Robbins Geller's Money Experts Clinch $1.2B Valeant Deal
The landmark $1.21 billion settlement for Valeant investors presented a tricky task of maximizing recovery without driving the financially embattled drug company into insolvency, prompting lead counsel Robbins Geller Rudman &...To view the full article, register now.
Already a subscriber? Click here to view full article